AstraZeneca Plc will invest $360 million building a new manufacturing facility for small molecules in Dublin, in a blow to U.K. hopes that the drugmaker would develop the site in its domestic market. ...
Source LinkAstraZeneca Plc will invest $360 million building a new manufacturing facility for small molecules in Dublin, in a blow to U.K. hopes that the drugmaker would develop the site in its domestic market. ...
Source Link
Comments